`571-272-7822
`
`Paper No. 101
`Entered: December 21, 2018
`
`
`UNITED STATES PATENT AND TRADEMARK OFFICE
`____________
`
`BEFORE THE PATENT TRIAL AND APPEAL BOARD
`____________
`
`ACRUX DDS PTY LTD., ACRUX LIMITED, and
`ARGENTUM PHARMACEUTICALS LLC,
`Petitioner,
`v.
`KAKEN PHARMACEUTICAL CO., LTD. and VALEANT
`PHARMACEUTICALS INTERNATIONAL, INC.,
`Patent Owner.
`
`
`Case IPR2017-001901
`Patent 7,214,506 B2
`
`
`
`
`
`
`
`Before SUSAN L. C. MITCHELL and ROBERT A. POLLOCK,
`Administrative Patent Judges.
`
`MITCHELL, Administrative Patent Judge.
`
`
`
`ORDER
`Conduct of the Proceeding
`37 C.F.R. § 42.5
`
`
`
`
`
`
`1 Case IPR2017-01429 has been joined with the instant proceeding.
`
`
`
`Case IPR2017-00190
`Patent 7,214,506 B2
`
`
`Kaken Pharmaceutical Co., Ltd. and Valeant Pharmaceuticals
`International, Inc., (“Patent Owner”) move to preserve the entire record and
`maintain under seal all non-public, currently sealed documents in this
`proceeding pending the outcome of all appeals. Paper 83, 5. Patent Owner
`notes that Patent Owner’s three unopposed motions to seal and Petitioner’s
`four unopposed motions to seal were granted, and the Board entered its
`default protective order to govern this proceeding. See id. at 1–2 (citing
`Papers 25, 59, 72 (Patent Owner’s motions to seal), Papers 36, 50, 62, 77
`(Petitioner’s motions to seal)).
`Specifically, Patent Owner moves “(i) to preserve and maintain under
`seal Exhibits 1663, 2093–2095, 2098, and 2099, unredacted versions of
`Exhibits 1506, 1507, 1511, and 2116, and unredacted versions of Papers 52,
`64, 69, and 74, and (ii) two weeks to file a motion to expunge after all
`opportunities for appeal.” Paper 83, 2. Patent Owner represents that it
`conferred with Acrux DDS Pty, Ltd, Acrux Limited, and Argentum
`Pharmaceuticals LLC (collectively, “Petitioners”), who proposed such
`preservation of the record until all appeals are completed. Id. at 1. Patent
`Owner filed a notice of appeal on August 7, 2018. Paper 86.
`We grant the Patent Owner’s Motion to reserve the record for appeal
`in IPR2017-00190.
`
`
`ORDER
`In consideration of the foregoing, it is hereby:
`ORDERED that the Motion is granted;
`FURTHER ORDERED that the record in IPR2017-00190 will be
`preserved, and the documents filed under seal will not be expunged or made
`
`
`
`
`
`2
`
`
`
`Case IPR2017-00190
`Patent 7,214,506 B2
`
`public during the pendency of an appeal for the case in which the sealed
`documents are part of the inter partes proceeding.
`FURTHER ORDERED that the parties will have fourteen days after
`the termination of an appeal to file a motion to expunge sealed confidential
`information in the case for which the appeal is terminated.
`
`
`
`
`
`
`
`
`
`
`
`
`3
`
`
`
`Case IPR2017-00190
`Patent 7,214,506 B2
`
`FOR PETITIONER:
`
`Tara Raghavan
`Steven J. Birkos
`RAKOCZY MOLINO MAZZOCHI SIWIK
`traghavan@rmmslegal.com
`sbirkos@rmmslegal.com
`
`
`FOR PATENT OWNER:
`
`John Livingstone
`Naoki Yoshida
`Anthony Hartmann
`Barbara R. Rudolph
`Trenton Ward
`FINNEGAN, HENDERSON, FARABOW,
` GARRETT & DUNNER, L.L.P.
`john.livingstone@finnegan.com
`naoki.yoshida@finnegan.com
`hartmana@finnegan.com
`Barbara.rudolph@finnegan.com
`Trenton.ward@finnegan.com
`
`Toan Vo
`BAUSCH HEALTH COMPANIES, INC.
`toan.vo@bausch.com
`
`
`
`
`
`
`
`4
`
`